MedTrace Logo

Evolution of the Quality of Life and Experience of Young Women With Utero-vaginal Aplasia (MRKHPSY)

NCT05415540 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2025-11-20

No results posted yet for this study

Summary

This study aims to evaluate the global evolution of the quality of life on patients diagnosed with MRKH syndrome (Mayer-Rokitansky-Kuster-Hauser), 8 to 10 years after the first research.

Conditions

  • Mrkh Syndrome

Interventions

OTHER

Questionnaires

Subjects included in the study will answer questionnaires

Sponsors & Collaborators

  • Foundation for Rare Diseases

    collaborator UNKNOWN

  • Necker Imagine Foundation

    collaborator UNKNOWN

  • Laboratory of Clinical Psychology, Psychopathology and Psychoanalysis

    collaborator UNKNOWN

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Alaa CHEIKHELARD, Doctor

  • Karinne Gueniche, MD, PhD

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-04
Primary Completion
2024-02-27
Completion
2024-02-27

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05415540 on ClinicalTrials.gov